Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Hay

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|December 2, 1998
Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progressionP Angulo, T M Therneau, A Jorgensen, et al.
Transplantation|November 15, 1996
Use of fatty donor liver is associated with diminished early patient and graft survivalW A Marsman, R H Wiesner, L Rodriguez, et al.
Mayo Clinic Proceedings|June 1, 1994
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinomaC K Tan, G J Gores, J L Steers, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitisR H Wiesner, M K Porayko, E R Dickson, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 30, 2008
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infectionB J Veldt, J J Poterucha, K D S Watt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis CB J Veldt, J J Poterucha, K D S Watt, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitisI W Graziadei, R H Wiesner, P J Marotta, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|December 2, 1998
Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progressionP Angulo, T M Therneau, A Jorgensen, et al.
Transplantation|November 15, 1996
Use of fatty donor liver is associated with diminished early patient and graft survivalW A Marsman, R H Wiesner, L Rodriguez, et al.
Mayo Clinic Proceedings|June 1, 1994
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinomaC K Tan, G J Gores, J L Steers, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitisR H Wiesner, M K Porayko, E R Dickson, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 30, 2008
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infectionB J Veldt, J J Poterucha, K D S Watt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis CB J Veldt, J J Poterucha, K D S Watt, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitisI W Graziadei, R H Wiesner, P J Marotta, et al.
Pageof 5